Literature DB >> 10777006

Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study.

N F Boyd1, H M Jensen, G Cooke, H L Han, G A Lockwood, A B Miller.   

Abstract

There is now a large amount of evidence indicating that women with extensive areas of mammographic densities are 4-6 times more likely to develop breast cancer than those with little or no density in the mammogram. We have examined one potential biological explanation for this association by estimating the incidence of various histological types of benign breast disease in relation to mammographic density. We studied the large cohort of women taking part in the National Breast Screening Study (NBSS), a randomized trial of screening with mammography. Mammograms from subjects with biopsies (n = 423) and from a comparison group of subjects randomly selected from the NBSS (n = 465) were included. Histological slides from biopsied subjects (n = 353) were classified independently by the pathologists of the NBSS and by a review pathologist (H.M.J.). Mammographic density in more than 75% of the breast area was associated with an increased risk of incidence of hyperplasia without atypia, and of atypical hyperplasia and/or carcinoma in situ. The classifications of the review pathologist showed that, compared to women with no density, the relative risk of incident lesions for women with density in more than 75% of breast was 13.85 (95% CI 2.65-72.49) for hyperplasia, and 9.23 (95% CI 1.66-51.48) for atypical hyperplasia and/or carcinoma in situ. These findings suggest that the association between extensive mammographic density and breast cancer risk may, at least in part, be attributable to biological processes in the breast that give rise to these histological features that are known to be related to breast cancer risk.

Entities:  

Mesh:

Year:  2000        PMID: 10777006     DOI: 10.1097/00008469-200002000-00003

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  27 in total

Review 1.  Clinical and epidemiological issues in mammographic density.

Authors:  Valentina Assi; Jane Warwick; Jack Cuzick; Stephen W Duffy
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

Review 2.  Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.

Authors:  Paola Nisticò; Mina J Bissell; Derek C Radisky
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 3.  A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.

Authors:  Michael S Shawky; Cecilia W Huo; Kara Britt; Erik W Thompson; Michael A Henderson; Andrew Redfern
Journal:  Breast Cancer Res Treat       Date:  2019-06-08       Impact factor: 4.872

4.  Reproductive and lifestyle risk factors and mammographic density in Mexican women.

Authors:  Megan S Rice; Kimberly A Bertrand; Martin Lajous; Rulla M Tamimi; Gabriela Torres; Ruy López-Ridaura; Isabelle Romieu
Journal:  Ann Epidemiol       Date:  2015-08-29       Impact factor: 3.797

Review 5.  Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?

Authors:  Derek C Radisky; Paraic A Kenny; Mina J Bissell
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

Review 6.  Tibolone and breast cancer.

Authors:  C Tamer Erel; Levent M Senturk; Semih Kaleli
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

7.  Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women.

Authors:  Angela K Green; Susan E Hankinson; Elizabeth R Bertone-Johnson; Rulla M Tamimi
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

Review 8.  Historical and epidemiologic background of human premalignant breast disease.

Authors:  D L Page; R A Jensen; J F Simpson; W D Dupont
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 9.  Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-05       Impact factor: 2.673

10.  Mammographic density and epithelial histopathologic markers.

Authors:  Martijn Verheus; Gertraud Maskarinec; Eva Erber; Jana S Steude; Jeffrey Killeen; Brenda Y Hernandez; J Mark Cline
Journal:  BMC Cancer       Date:  2009-06-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.